Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrick Grace Insider Profile
4 Followers
Patrick Grace, Director at Tonix Pharma, holds 3.27K shares in Chemed (Ticker: CHE), holds 2.75K shares in Tonix Pharma (Ticker: TNXP). Most recently, Patrick Grace Sold ― shares of Chemed on May 30, 2023 for an estimated value of 160.01K.
Profitable Transactions
2 out of 12 Profitable Transactions
Average Return
-23.80%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Most Profitable Insider Trade
The most profitable trade made by Patrick Grace
Patrick Grace's Trading History
Tonix Pharma
Jan 14, 2013
Director
Uninformative Buy
―
$429.78
Chemed
May 30, 2023
Director
Informative Sell
160.01K
$2.02M
List of latest transactions for each holding click on a transaction to see Patrick Grace's performance on stock
You May Also Like
Patrick Grace insider profile FAQ
What is the percentage of profitable transactions made by Patrick Grace?
The percentage of profitable transactions made by Patrick Grace is 17%.
What is the average return per transaction made by Patrick Grace?
The average return per transaction made by Patrick Grace is -23.80%.
What stocks does Patrick Grace hold?
Patrick Grace holds: TNXP, CHE stocks.
What was Patrick Grace’s latest transaction?
Patrick Grace latest transaction was an Informative Sell of $160.01K.
What was Patrick Grace's most profitable transaction?
Patrick Grace’s most profitable transaction was an Informative Sell of CHE stock on August 24, 2015. The return on the trade was 3.50%.
What is Patrick Grace's role in Tonix Pharma?
Patrick Grace's role in Tonix Pharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.